Clinical Trials Directory

Trials / Completed

CompletedNCT05296863

Adipose-derived Stem Cell Conditioned Media as a Novel Approach for Hair Regrowth in Male Androgenetic Alopecia

Adipose-derived Stem Cell Conditioned Media as a Novel Approach for Hair Regrowth in Male Androgenetic Alopecia: A Randomized, Double-blind Clinical Trial

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
37 (actual)
Sponsor
Dr. dr. Lili Legiawati, SpKK(K) · Academic / Other
Sex
Male
Age
25 Years – 58 Years
Healthy volunteers
Accepted

Summary

This study investigated the efficacy of adipose derived stem cell conditioned media (ADSC-CM) combined with minoxidil for hair regeneration therapy in male AGA.

Detailed description

This study was a double-blind, randomized clinical trial (RCT). Two concentrations of ADSC-CM were utilized: concentrated and non-concentrated ADSC-CM. The scalp was divided vertically in half; one side was injected with 2 ml of ADSC-CM, while the control side received 2 ml of NaCl 0,9%. After the injection, patients applied topical 5% minoxidil twice daily. Clinical improvements were assessed using photographic evaluation and trichoscan every two weeks.

Conditions

Interventions

TypeNameDescription
COMBINATION_PRODUCTNon-concentrated adipose-derived stem cell conditioned media and 5% MinoxidilNon-concentrated ADSC-CM is given during week 0, 2, 4, and 6 on the left side of the scalp. Minoxidil is applied twice using a spray, in the morning and at night.
COMBINATION_PRODUCTConcentrated adipose-derived stem cell conditioned media and 5% MinoxidilIntervention is given during week 0, 2, 4, and 6 on the left side of the scalp. Minoxidil is applied twice using a spray, in the morning and at night.
COMBINATION_PRODUCTPlacebo and 5% MinoxidilIntervention is given during week 0, 2, 4, and 6 on the right side of the scalp. Minoxidil is applied twice using a spray, in the morning and at night.

Timeline

Start date
2021-10-11
Primary completion
2021-12-03
Completion
2021-12-03
First posted
2022-03-25
Last updated
2022-03-25

Locations

1 site across 1 country: Indonesia

Source: ClinicalTrials.gov record NCT05296863. Inclusion in this directory is not an endorsement.